These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30301860)

  • 1. Renal COP9 Signalosome Deficiency Alters CUL3-KLHL3-WNK Signaling Pathway.
    Cornelius RJ; Si J; Cuevas CA; Nelson JW; Gratreak BDK; Pardi R; Yang CL; Ellison DH
    J Am Soc Nephrol; 2018 Nov; 29(11):2627-2640. PubMed ID: 30301860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distal convoluted tubule-specific disruption of the COP9 signalosome but not its regulatory target cullin 3 causes tubular injury.
    Maeoka Y; Bradford T; Su XT; Sharma A; Yang CL; Ellison DH; McCormick JA; Cornelius RJ
    Am J Physiol Renal Physiol; 2024 Oct; 327(4):F667-F682. PubMed ID: 39205661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Kelch-like 3 and Cullin 3 Degradation is a Central Mechanism in Familial Hyperkalemic Hypertension in Mice.
    Maeoka Y; Ferdaus MZ; Cornelius RJ; Sharma A; Su XT; Miller LN; Robertson JA; Gurley SB; Yang CL; Ellison DH; McCormick JA
    J Am Soc Nephrol; 2022 Mar; 33(3):584-600. PubMed ID: 35064051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperkalemic hypertension-associated cullin 3 promotes WNK signaling by degrading KLHL3.
    McCormick JA; Yang CL; Zhang C; Davidge B; Blankenstein KI; Terker AS; Yarbrough B; Meermeier NP; Park HJ; McCully B; West M; Borschewski A; Himmerkus N; Bleich M; Bachmann S; Mutig K; Argaiz ER; Gamba G; Singer JD; Ellison DH
    J Clin Invest; 2014 Nov; 124(11):4723-36. PubMed ID: 25250572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual gain and loss of cullin 3 function mediates familial hyperkalemic hypertension.
    Cornelius RJ; Zhang C; Erspamer KJ; Agbor LN; Sigmund CD; Singer JD; Yang CL; Ellison DH
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1006-F1018. PubMed ID: 29897280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COP9 signalosome deletion promotes renal injury and distal convoluted tubule remodeling.
    Cornelius RJ; Nelson JW; Su XT; Yang CL; Ellison DH
    Am J Physiol Renal Physiol; 2022 Jul; 323(1):F4-F19. PubMed ID: 35532068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
    Ohta A; Schumacher FR; Mehellou Y; Johnson C; Knebel A; Macartney TJ; Wood NT; Alessi DR; Kurz T
    Biochem J; 2013 Apr; 451(1):111-22. PubMed ID: 23387299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased KLHL3 expression is involved in the activation of WNK-OSR1/SPAK-NCC cascade in type 1 diabetic mice.
    Guo Q; Zhang Y; Jiang GR; Zhang C
    Pflugers Arch; 2021 Feb; 473(2):185-196. PubMed ID: 33432425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation by Cullin 3 and effect on WNK kinases suggest a role of KLHL2 in the pathogenesis of Familial Hyperkalemic Hypertension.
    Zhang C; Meermeier NP; Terker AS; Blankenstein KI; Singer JD; Hadchouel J; Ellison DH; Yang CL
    Biochem Biophys Res Commun; 2016 Jan; 469(1):44-48. PubMed ID: 26607111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
    Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
    Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation affecting the conserved acidic WNK1 motif causes inherited hyperkalemic hyperchloremic acidosis.
    Louis-Dit-Picard H; Kouranti I; Rafael C; Loisel-Ferreira I; Chavez-Canales M; Abdel-Khalek W; Argaiz ER; Baron S; Vacle S; Migeon T; Coleman R; Do Cruzeiro M; Hureaux M; Thurairajasingam N; Decramer S; Girerd X; O'Shaugnessy K; Mulatero P; Roussey G; Tack I; Unwin R; Vargas-Poussou R; Staub O; Grimm R; Welling PA; Gamba G; Clauser E; Hadchouel J; Jeunemaitre X
    J Clin Invest; 2020 Dec; 130(12):6379-6394. PubMed ID: 32790646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of KLHL3 and dietary K
    Ostrosky-Frid M; Chávez-Canales M; Zhang J; Andrukhova O; Argaiz ER; Lerdo-de-Tejada F; Murillo-de-Ozores A; Sanchez-Navarro A; Rojas-Vega L; Bobadilla NA; Vazquez N; Castañeda-Bueno M; Alessi DR; Gamba G
    Am J Physiol Renal Physiol; 2021 May; 320(5):F734-F747. PubMed ID: 33682442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of the Cullin-3 mutation that causes a severe form of familial hypertension and hyperkalaemia.
    Schumacher FR; Siew K; Zhang J; Johnson C; Wood N; Cleary SE; Al Maskari RS; Ferryman JT; Hardege I; Yasmin ; Figg NL; Enchev R; Knebel A; O'Shaughnessy KM; Kurz T
    EMBO Mol Med; 2015 Oct; 7(10):1285-306. PubMed ID: 26286618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of the WNK4-SPAK/OSR1 pathway has a minor effect on baseline NKCC2 phosphorylation.
    Maeoka Y; Nguyen LT; Sharma A; Cornelius RJ; Su XT; Gutierrez MR; Carbajal-Contreras H; Castañeda-Bueno M; Gamba G; McCormick JA
    Am J Physiol Renal Physiol; 2024 Jan; 326(1):F39-F56. PubMed ID: 37881876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROMK expression remains unaltered in a mouse model of familial hyperkalemic hypertension caused by the CUL3Δ403-459 mutation.
    Murthy M; Kurz T; O'Shaughnessy KM
    Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27378813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension-causing cullin 3 mutations disrupt COP9 signalosome binding.
    Cornelius RJ; Yang CL; Ellison DH
    Am J Physiol Renal Physiol; 2020 Jan; 318(1):F204-F208. PubMed ID: 31813255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.
    Susa K; Sohara E; Rai T; Zeniya M; Mori Y; Mori T; Chiga M; Nomura N; Nishida H; Takahashi D; Isobe K; Inoue Y; Takeishi K; Takeda N; Sasaki S; Uchida S
    Hum Mol Genet; 2014 Oct; 23(19):5052-60. PubMed ID: 24821705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cullin 3 mutant causing familial hyperkalemic hypertension lacks normal activity in the kidney.
    Maeoka Y; Cornelius RJ; Ferdaus MZ; Sharma A; Nguyen LT; McCormick JA
    Am J Physiol Renal Physiol; 2022 Nov; 323(5):F564-F576. PubMed ID: 36007890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant Cullin 3 causes familial hyperkalemic hypertension via dominant effects.
    Ferdaus MZ; Miller LN; Agbor LN; Saritas T; Singer JD; Sigmund CD; McCormick JA
    JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel
    Chatrathi HE; Collins JC; Wolfe LA; Markello TC; Adams DR; Gahl WA; Werner A; Sharma P
    Hypertension; 2022 Jan; 79(1):60-75. PubMed ID: 34878901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.